GSK plc Additions Other Than Through Business Combinations Rightofuse Assets
GSK plc (GLAXF) reported Additions Other Than Through Business Combinations Rightofuse Assets of GBP 181.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Notes
ifrs-full:AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets · last filed 2026-03-06
| Period end | Additions Other Than Through Business Combinations Rightofuse Assets 12 month |
|---|---|
| 2025-12-31 | 181.00M GBP 20-F · filed 2026-03-06 |
| 2024-12-31 | 230.00M GBP 20-F · filed 2026-03-06 |
| 2023-12-31 | 499.00M GBP 20-F · filed 2025-03-03 |